Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 14, 2016, Pages 3855-3860

  Peng, Chen ^a   Haller, Sherry L ^a   Rahman, Masmudur M ^b   McFadden, Grant ^b   Rothenburg, Stefan ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Host pathogen interaction; Myxoma virus; PKR; Poxvirus; Translational regulation

Indexed keywords

ALANINE; COMPLEMENTARY DNA; INITIATION FACTOR 2ALPHA; MYXOMA VIRUS PROTEIN M T7; MYXOMA VIRUS PROTEIN M029L; MYXOMA VIRUS PROTEIN M130; MYXOMA VIRUS PROTEIN M156; MYXOMA VIRUS PROTEIN M156R; PROTEIN KINASE R; UNCLASSIFIED DRUG; VACCINIA VIRUS E3 PROTEIN; VACCINIA VIRUS K3 PROTEIN; VALINE; VIRUS PROTEIN; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL LEVEL; CELL SIZE; CONTROLLED STUDY; ECTOPIC EXPRESSION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; FEMALE; FUNGAL STRAIN; FUNGUS GROWTH; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL LINE; HOST RANGE; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MOLECULAR WEIGHT; MYXOMA VIRUS; MYXOMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; START CODON; VIRUS ACTIVATION; VIRUS ATTENUATION; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; AUSTRALIA; GENETICS; METABOLISM; MUTATION; PATHOGENICITY; RABBITS AND HARES; TUMOR CELL LINE; VIRULENCE;

ANIMALS; AUSTRALIA; CELL LINE, TUMOR; EIF-2 KINASE; HELA CELLS; HUMANS; MUTATION; MYXOMA VIRUS; RABBITS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84962737715     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1515613113     Document Type: Article

References (29)

1. Seet BT, et al. (2003) Poxviruses and immune evasion. Annu Rev Immunol 21:377-423.
2. Haller SL, Peng C, McFadden G, Rothenburg S (2014) Poxviruses and the evolution of host range and virulence. Infect Genet Evol 21:15-40.
3. Werden SJ, Rahman MM, McFadden G (2008) Poxvirus host range genes. Adv Virus Res 71:135-171.
4. Bratke KA, McLysaght A, Rothenburg S (2013) A survey of host range genes in poxvirus genomes. Infect Genet Evol 14:406-425.
5. Kerr PJ (2012) Myxomatosis in Australia and Europe: A model for emerging infectious diseases. Antiviral Res 93(3):387-415.
6. Kerr PJ, et al. (2012) Evolutionary history and attenuation of myxoma virus on two continents. PLoS Pathog 8(10):e1002950.
7. Kerr PJ, et al. (2013) Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread. J Virol 87(23):12900-12915.
8. Davies MV, Chang HW, Jacobs BL, Kaufman RJ (1993) The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNAdependent protein kinase by different mechanisms. J Virol 67(3):1688-1692.
9. Langland JO, Jacobs BL (2002) The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299(1):133-141.
10. Rothenburg S, Seo EJ, Gibbs JS, Dever TE, Dittmar K (2009) Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat Struct Mol Biol 16(1):63-70.
11. Elde NC, Child SJ, Geballe AP, Malik HS (2009) Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457(7228):485-489.
12. Ramelot TA, et al. (2002) Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha. J Mol Biol 322(5):943-954.
13. Cameron C, et al. (1999) The complete DNA sequence of myxoma virus. Virology 264(2):298-318.
14. Willer DO, McFadden G, Evans DH (1999) The complete genome sequence of shope (rabbit) fibroma virus. Virology 264(2):319-343.
15. Kerr PJ, et al. (2013) Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations. J Virol 87(22):12080-12089.
16. Kawagishi-Kobayashi M, Silverman JB, Ung TL, Dever TE (1997) Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha. Mol Cell Biol 17(7):4146-4158.
17. Kawagishi-Kobayashi M, Cao C, Lu J, Ozato K, Dever TE (2000) Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 276(2): 424-434.
18. Rothenburg S, Chinchar VG, Dever TE (2011) Characterization of a ranavirus inhibitor of the antiviral protein kinase PKR. BMC Microbiol 11:56.
19. Kuhen KL, Samuel CE (1997) Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5′-flanking region of human and mouse Pkr genes. Virology 227(1):119-130.
20. Johnston JB, et al. (2003) Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J Virol 77(10):5877-5888.
21. Rahman MM, Liu J, Chan WM, Rothenburg S, McFadden G (2013) Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication. PLoS Pathog 9(7):e1003465.
22. Dar AC, Dever TE, Sicheri F (2005) Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell 122(6):887-900.
23. Dar AC, Sicheri F (2002) X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol Cell 10(2):295-305.
24. Zhang P, Samuel CE (2007) Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 81(15):8192-8200.
25. Dever TE, et al. (1992) Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68(3):585-596.
26. Brennan G, Kitzman JO, Rothenburg S, Shendure J, Geballe AP (2014) Adaptive gene amplification as an intermediate step in the expansion of virus host range. PLoS Pathog 10(3):e1004002.
27. Liu J, et al. (2012) Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host range factors that controls the kinetics of myxomatosis in European rabbits. J Virol 86(9):5371-5375.
28. Mossman K, et al. (1996) Myxoma virus M-T7, a secreted homolog of the interferongamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215(1):17-30.
29. Barrett JW, et al. (2009) Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Virus Res 144(1-2):258-265.